SAMUEL D COLELLA
CIK 1201580 · last filed 2021-11-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$170.64M
Companies
11
Total Filings
110
Lifetime Open-Market Net
$103.63M
Filer Profile
Reported Address
ONE SANSOME STREETSUITE 3630
SAN FRANCISCO, CA 94104
Related Filers
BRIAN G ATWOOD — 30 joint filings, latest 2016-06-10
ROSS A MD JAFFE — 30 joint filings, latest 2016-06-10
DONALD B MILDER — 30 joint filings, latest 2016-06-10
WILLIAM J PHD LINK — 22 joint filings, latest 2016-06-10
Versant Affiliates Fund II-A, LP — 20 joint filings, latest 2015-05-11
Versant Side Fund II, LP — 20 joint filings, latest 2015-05-11
Versant Venture Capital II, LP — 20 joint filings, latest 2015-05-11
Versant Ventures II LLC — 20 joint filings, latest 2015-05-11
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.
View filings on SEC EDGAR.
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FLXN | Director | 0 | $24.67 | $0 | $115.22M | 21 | 2021-11-19 |
| STANDARD BIOTOOLS INC. (FLDM) Delisted | Director | 230,381 | $3.71 | $854.7K | -$2.05M | 35 | 2020-03-12 |
| GKOS | 10%+ Owner | 397 | $162.63 | $64.6K | -$8.17M | 2 | 2016-06-02 |
| INGN | 10%+ Owner | 58,495 | $5.16 | $301.5K | -$1.62M | 2 | 2015-05-11 |
| GENOMIC HEALTH INC (GHDX) Delisted | Director | 41,742 | — | — | -$4.64M | 27 | 2014-10-03 |
| VCYT | Director | 3,594,989 | $42.92 | $154.30M | $0 | 1 | 2013-11-04 |
| Alexza Pharmaceuticals Inc. (ALXA) Delisted | Director | 4,730 | — | — | $0 | 8 | 2012-09-07 |
| JAZZ | Director | 44,024 | $241.29 | $10.62M | $0 | 10 | 2012-01-13 |
| HELICOS BIOSCIENCES CORP (HLCS) Delisted | 10%+ Owner | 10,709,818 | — | — | $4.88M | 2 | 2009-09-21 |
| SYMYX TECHNOLOGIES INC (SMMX) Delisted | Director | 11,938 | — | — | $0 | 1 | 2007-06-14 |
| PODD | 38,301 | $139.93 | $5.36M | $0 | 1 | 2007-05-17 |
Recent Filings · Page 11 of 11
110 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2008-07-23 | JAZZ | Buy (P) | +296,022 | $0 | EDGAR |
| 2008-05-28 | Alexza Pharmaceuticals Inc. (ALXA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2008-05-27 | GENOMIC HEALTH INC (GHDX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-08-16 | JAZZ | Grant (A) | — | $0 | EDGAR |
| 2007-06-14 | SYMYX TECHNOLOGIES INC (SMMX) Delisted | Grant (A) | +4,546 | $0 | EDGAR |
| 2007-06-14 | GENOMIC HEALTH INC (GHDX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-06-06 | JAZZ | Conv (C) | +1,234,161 | $0 | EDGAR |
| 2007-06-01 | HELICOS BIOSCIENCES CORP (HLCS) Delisted | Mixed | +6,405,816 | $3.00M | EDGAR |
| 2007-05-24 | Alexza Pharmaceuticals Inc. (ALXA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-05-17 | PODD | Conv (C) | +2,127,943 | $0 | EDGAR |
Showing 101–110 of 110
Prev
Page 11 of 11
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.